FDA Takes Hands-Off Approach to AI Devices and Software

Summary

• The FDA will not regulate low-risk AI-enabled health wearable devices and clinical decision support software. • This hands-off approach is intended to promote market innovation.

Why It Matters for Texas Credit Unions

Texas credit unions may be interested in how this guidance affects their operations, especially concerning any AI technologies they might use or develop for health-related services.

Original Source Material

Agency: Guidance Favors Market Innovation Over Federal Scrutiny New artificial intelligence-enabled health wearable devices and clinical decision support software will not face U.S. Food and Drug Administration regulatory scrutiny, providing the technology meets certain criteria, such as being "low-risk," the agency said this week.